Strojan P - Search Results

1

Serum cystatin C in patients with head and neck carcinoma.

Strojan P, Svetic B, Smid L, Kos J. Strojan P, et al. Clin Chim Acta. 2004 Jun;344(1-2):155-61. doi: 10.1016/j.cccn.2004.02.011. Clin Chim Acta. 2004. PMID: 15149884

2

Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.

Budihna M, Strojan P, Smid L, Skrk J, Vrhovec I, Zupevc A, Rudolf Z, Zargi M, Krasovec M, Svetic B, Kopitar-Jerala N, Kos J. Budihna M, et al. Among authors: strojan p. Biol Chem Hoppe Seyler. 1996 Jun;377(6):385-90. doi: 10.1515/bchm3.1996.377.6.385. Biol Chem Hoppe Seyler. 1996. PMID: 8839984 Clinical Trial.

3

Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma.

Smid L, Strojan P, Budihna M, Skrk J, Vrhovec I, Zargi M, Kos J. Smid L, et al. Among authors: strojan p. Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S150-3. doi: 10.1007/BF02439748. Eur Arch Otorhinolaryngol. 1997. PMID: 9065652

4

Cathepsin D in tissue and serum of patients with squamous cell carcinoma of the head and neck.

Strojan P, Budihna M, Smid L, Vrhovec I, Skrk J. Strojan P, et al. Cancer Lett. 1998 Aug 14;130(1-2):49-56. doi: 10.1016/s0304-3835(98)00114-1. Cancer Lett. 1998. PMID: 9751256

5

Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients.

Strojan P, Budihna M, Smid L, Vrhovec I, Skrk J. Strojan P, et al. Eur J Cancer. 1998 Jul;34(8):1193-7. doi: 10.1016/s0959-8049(98)00029-x. Eur J Cancer. 1998. PMID: 9849478

6

Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck.

Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Kos J, Skrk J. Strojan P, et al. Clin Cancer Res. 2000 Mar;6(3):1052-62. Clin Cancer Res. 2000. PMID: 10741734

7

Urokinase-type plasminogen activator, plasminogen activator inhibitor type 1 and cathepsin D: analysis of their prognostic significance in squamous cell carcinoma of the head and neck.

Strojan P, Budihna M, Smid L, Vrhovec I, Skrk J. Strojan P, et al. Anticancer Res. 2000 Sep-Oct;20(5C):3975-81. Anticancer Res. 2000. PMID: 11268487

8

Cathepsin B and L and stefin A and B levels as serum tumor markers in squamous cell carcinoma of the head and neck.

Strojan P, Budihna M, Smid L, Svetic B, Vrhovec I, Skrk J. Strojan P, et al. Neoplasma. 2001;48(1):66-71. Neoplasma. 2001. PMID: 11327540

9

Postoperative concomitant irradiation and chemotherapy with mitomycin C and bleomycin for advanced head-and-neck carcinoma.

Smid L, Budihna M, Zakotnik B, Soba E, Strojan P, Fajdiga I, Zargi M, Oblak I, Dremelj M, LeSnicar H. Smid L, et al. Among authors: strojan p. Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1055-62. doi: 10.1016/s0360-3016(03)00207-4. Int J Radiat Oncol Biol Phys. 2003. PMID: 12829141 Clinical Trial.

10

Hemoglobin as a factor influencing the outcome in inoperable oropharyngeal carcinoma treated by concomitant radiochemotherapy.

Oblak I, Strojan P, Zakotnik B, Budihna M, Smid L. Oblak I, et al. Among authors: strojan p. Neoplasma. 2003;50(6):452-8. Neoplasma. 2003. PMID: 14689069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters